Clinical Trial: A Study to Evaluate the Effects of an Investigational Drug on the Postprandial (following a meal) Lipoprotein Response in Patients with Primary Hypercholesterolemia (high cholesterol)
This study is currently recruiting patients.
|Condition||Treatment or Intervention||Phase|
|Hypercholesterolemia || ||Phase II |
MedlinePlus related topics: Cholesterol
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both
- Eligible patients will be otherwise healthy men and women (if not on oral contraceptives or hormone replacement therapy) 18 through 70 years of age with moderately high cholesterol.
- Individuals on other lipid-lowering therapy (medicines that lower cholesterol) including statins (within 6 weeks) and fibrates (within 8 weeks) prior to administration of the study drug.
Location and Contact Information
Call for Information, Berkeley, California, 94705, United States; Recruiting
Record last reviewed: March 2005
Last Updated: March 18, 2005
Record first received: January 10, 2005
ClinicalTrials.gov Identifier: NCT00101439
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Cache Date: April 9, 2005